Pulike Biological Engineering Gelecekteki Büyüme
Future kriter kontrolleri 4/6
Pulike Biological Engineering is forecast to grow earnings and revenue by 32.8% and 16.5% per annum respectively. EPS is expected to grow by 33.1% per annum. Return on equity is forecast to be 9.1% in 3 years.
Anahtar bilgiler
32.8%
Kazanç büyüme oranı
33.1%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 19.3% |
Gelir büyüme oranı | 16.5% |
Gelecekteki özkaynak getirisi | 9.1% |
Analist kapsamı | Good |
Son güncelleme | 31 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Pulike Biological Engineering's (SHSE:603566) Weak Earnings May Only Reveal A Part Of The Whole Picture
Sep 04Pulike Biological Engineering, Inc. (SHSE:603566) Looks Just Right With A 34% Price Jump
May 21Need To Know: The Consensus Just Cut Its Pulike Biological Engineering, Inc. (SHSE:603566) Estimates For 2024
Apr 28Why Investors Shouldn't Be Surprised By Pulike Biological Engineering, Inc.'s (SHSE:603566) Low P/E
Mar 21Pulike Biological Engineering (SHSE:603566) Seems To Use Debt Quite Sensibly
Feb 28Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 1,636 | 284 | N/A | 390 | 6 |
12/31/2025 | 1,426 | 254 | N/A | 302 | 7 |
12/31/2024 | 1,270 | 206 | N/A | 273 | 7 |
9/30/2024 | 1,082 | 103 | 86 | 221 | N/A |
6/30/2024 | 1,118 | 132 | 85 | 257 | N/A |
3/31/2024 | 1,181 | 138 | 3 | 246 | N/A |
12/31/2023 | 1,253 | 175 | -22 | 283 | N/A |
9/30/2023 | 1,329 | 225 | -144 | 251 | N/A |
6/30/2023 | 1,335 | 204 | -213 | 221 | N/A |
3/31/2023 | 1,292 | 194 | -148 | 269 | N/A |
12/31/2022 | 1,230 | 168 | -129 | 228 | N/A |
9/30/2022 | 1,105 | 142 | -124 | 252 | N/A |
6/30/2022 | 1,032 | 161 | -90 | 271 | N/A |
3/31/2022 | 1,035 | 195 | -129 | 219 | N/A |
12/31/2021 | 1,099 | 244 | -105 | 213 | N/A |
9/30/2021 | 1,102 | 298 | 42 | 245 | N/A |
6/30/2021 | 1,086 | 271 | 35 | 218 | N/A |
3/31/2021 | 1,044 | 255 | 62 | 245 | N/A |
12/31/2020 | 929 | 228 | 85 | 262 | N/A |
9/30/2020 | 840 | 175 | 62 | 218 | N/A |
6/30/2020 | 765 | 164 | 84 | 205 | N/A |
3/31/2020 | 709 | 154 | 95 | 191 | N/A |
12/31/2019 | 663 | 109 | 55 | 140 | N/A |
9/30/2019 | 648 | 112 | 55 | 136 | N/A |
6/30/2019 | 642 | 124 | 13 | 84 | N/A |
3/31/2019 | 612 | 111 | 35 | 91 | N/A |
12/31/2018 | 608 | 136 | 73 | 126 | N/A |
9/30/2018 | 580 | 141 | 92 | 135 | N/A |
6/30/2018 | 557 | 129 | N/A | 159 | N/A |
3/31/2018 | 541 | 119 | N/A | 134 | N/A |
12/31/2017 | 530 | 114 | N/A | 141 | N/A |
9/30/2017 | 537 | 124 | N/A | 218 | N/A |
6/30/2017 | 592 | 160 | N/A | 209 | N/A |
3/31/2017 | 599 | 178 | N/A | 225 | N/A |
12/31/2016 | 583 | 188 | N/A | 253 | N/A |
9/30/2016 | 543 | 181 | N/A | 206 | N/A |
6/30/2016 | 505 | 161 | N/A | 193 | N/A |
3/31/2016 | 465 | 139 | N/A | 187 | N/A |
12/31/2015 | 478 | 142 | N/A | 187 | N/A |
9/30/2015 | 467 | 152 | N/A | 166 | N/A |
6/30/2015 | 486 | 158 | N/A | 165 | N/A |
3/31/2015 | 499 | 161 | N/A | 148 | N/A |
12/31/2014 | 476 | 140 | N/A | 151 | N/A |
12/31/2013 | 472 | 163 | N/A | 181 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 603566's forecast earnings growth (32.8% per year) is above the savings rate (2.9%).
Kazançlar ve Piyasa: 603566's earnings (32.8% per year) are forecast to grow faster than the CN market (25.7% per year).
Yüksek Büyüme Kazançları: 603566's earnings are expected to grow significantly over the next 3 years.
Gelir ve Pazar: 603566's revenue (16.5% per year) is forecast to grow faster than the CN market (14.1% per year).
Yüksek Büyüme Geliri: 603566's revenue (16.5% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 603566's Return on Equity is forecast to be low in 3 years time (9.1%).